Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.21.2
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Total
Additional Paid-in Capital
Accumulated Deficit
Class B Ordinary Shares
Beginning balance at Dec. 31, 2020 $ 6,380 $ 22,556 $ (18,620) $ 2,444
Beginning balance (in shares) at Dec. 31, 2020       24,437,500
Excess of cash receipts over the fair value of the private warrants sold to Sponsor 6,858,410 6,858,410    
Accrection on Class A ordinary shares subject to possible redemption (73,159,437) (6,880,966) (66,278,471)  
Net loss (2,223,991)   (2,223,991)  
Ending balance at Mar. 31, 2021 (68,518,638) 0 (68,521,082) $ 2,444
Ending balance (in shares) at Mar. 31, 2021       24,437,500
Beginning balance at Dec. 31, 2020 6,380 22,556 (18,620) $ 2,444
Beginning balance (in shares) at Dec. 31, 2020       24,437,500
Net loss (6,220,241)     $ (1,207,645)
Ending balance at Sep. 30, 2021 (72,514,888) 0 (72,517,332) $ 2,444
Ending balance (in shares) at Sep. 30, 2021       24,437,500
Beginning balance at Mar. 31, 2021 (68,518,638) 0 (68,521,082) $ 2,444
Beginning balance (in shares) at Mar. 31, 2021       24,437,500
Net loss (3,605,725)   (3,605,725)  
Ending balance at Jun. 30, 2021 (72,124,363) 0 (72,126,807) $ 2,444
Ending balance (in shares) at Jun. 30, 2021       24,437,500
Net loss (390,525)   (390,525) $ (78,105)
Ending balance at Sep. 30, 2021 $ (72,514,888) $ 0 $ (72,517,332) $ 2,444
Ending balance (in shares) at Sep. 30, 2021       24,437,500